Product Description
Overall, the global anti-reflux device market was valued at $114.2 million in 2021. This is expected to increase over the forecast period at a CAGR of 23% to reach $486.3 million.
The full report suite on the global market for anti-reflux devices includes a variety of procedure techniques to treat GERD, such as transoral incisionless fundoplication (TIF), transesophageal radiofrequency and the LINX® technique.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
The anti-reflux device implementation procedure market has historically been limited by large untreated populations, as well as competition from medicinal treatments. The surgeons, however, have been promoting this procedure to individuals as a way to market their practice and diversify their surgical offerings. With the procedure becoming more popular, growth rates are expected to remain strong.
GLOBAL ANTI-REFLUX DEVICE MARKET TRENDS
The value of the anti-reflux device market decreased in 2020, due to the mass cancelation of elective surgical procedures during the COVID-19 pandemic. However, as recovery continued in 2021, strong growth is expected over the forecast period.
GLOBAL ANTI-REFLUX DEVICE MARKET SHARE INSIGHTS
Overall, within the global anti-reflux device market there are three dominant competitors: Johnson & Johnson, EndoGastric Solutions, and Restech.
In 2021, the leading competitor in the anti-reflux device market was Johnson & Johnson. Johnson & Johnson offers the LINX® reflux management system. This device is essentially a flexible band of interlinked titanium beads with magnetic cores that is wrapped around the lower part of the esophagus.
MARKET SEGMENTATION SUMMARY
-
Global Anti-Reflux Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
